GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » YoY EPS Growth

BioVaxys Technology (BioVaxys Technology) YoY EPS Growth : 0.00% (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. BioVaxys Technology's YoY EPS Growth for the quarter that ended in Jul. 2023 was 0.00%.

BioVaxys Technology's Earnings per Share (Diluted) for the three months ended in Jul. 2023 was $-0.01.


BioVaxys Technology YoY EPS Growth Historical Data

The historical data trend for BioVaxys Technology's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology YoY EPS Growth Chart

BioVaxys Technology Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22
YoY EPS Growth
- - -88.24 -100.00 -37.50

BioVaxys Technology Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -175.00 12.50 12.50 -

BioVaxys Technology YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

BioVaxys Technology's YoY EPS Growth for the fiscal year that ended in Oct. 2022 is calculated as:

YoY EPS Growth (A: Oct. 2022 )
=(Earnings per Share (Diluted) (A: Oct. 2022 )-Earnings per Share (Diluted) (A: Oct. 2021 ))/ | Earnings per Share (Diluted) (A: Oct. 2021 ) |
=(-0.088--0.064)/ | -0.064 |
=-37.50 %

BioVaxys Technology's YoY EPS Growth for the quarter that ended in Jul. 2023 is calculated as:

YoY EPS Growth (Q: Jul. 2023 )
=(Earnings per Share (Diluted) (Q: Jul. 2023 )-Earnings per Share (Diluted) (Q: Jul. 2022 )) / | Earnings per Share (Diluted) (Q: Jul. 2022 )) |
=(-0.008--0.008)/ | -0.008 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioVaxys Technology YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


BioVaxys Technology (BioVaxys Technology) Business Description

Traded in Other Exchanges
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.